Home > PS Ratio > SAKAR HEALTHCARE

SAKAR HEALTHCARE
PS (Price/Sales) Ratio

The Current P/S Ratio of SAKAR HEALTHCARE is 3.28.

Share Price ₹255.1Mar 10,2025
Market Cap ₹558.6 Cr
Sales-TTM₹170.4 CrTTM-Consolidated Results
Price/Sales3.28xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results
SAKAR HEALTHCARE is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of SAKAR HEALTHCARE

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SAKAR HEALTHCARE is calculated as :

Current Market Cap [ ₹558.6 Cr] as on Mar 10,2025

(/) Sales [ ₹170.4 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 3.28x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay '3.28 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SAKAR HEALTHCARE !

The chart below summarizes the trend in P/S Ratio of SAKAR HEALTHCARE over the last five years.

Historical PS (Price/Sales) ratio chart of SAKAR HEALTHCARE


PS Ratio Performance Analysis for SAKAR HEALTHCARE

- SAKAR HEALTHCARE 's latest p/e ratio is 3.28x.

- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.53x.

- SAKAR HEALTHCARE 's operated at median p/e ratio of 1.86x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 5.22x.

- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 0.9x.


How does SAKAR HEALTHCARE 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SAKAR HEALTHCARE 170.43.28558.6
SUN PHARMACEUTICAL INDUSTRIES LTD51,602.57.70397,246.0
DIVIS LABORATORIES LTD9,078.016.21147,119.0
CIPLA LTD26,981.24.33116,805.0
TORRENT PHARMACEUTICALS LTD11,302.09.16103,554.0
DR REDDYS LABORATORIES LTD31,229.32.9893,192.0
MANKIND PHARMA LTD11,641.07.8391,196.4
ZYDUS LIFESCIENCES LTD22,247.44.0790,551.0
LUPIN LTD22,001.64.1090,226.2
AUROBINDO PHARMA LTD30,921.82.0563,368.4
ABBOTT INDIA LTD6,243.210.3864,826.7

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SAKAR HEALTHCARE 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.05x
Max industry PS 16.21x
Median industry PS 4.33x
Average industry PS 6.55x



You may also like the below Video Courses